Novavax (NVAX) Stock Up 8% Yesterday as FDA Approves Updated Covid Vaccine but Is 6% Down Now
The updated vaccine specifically addresses the XBB.1.5 subvariant of the Omicron variant, which has raised concerns due to its potential to evade immunity conferred by earlier versions of the vaccine.